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ABSTRACT 
Digoxin is a cardiac glycoside that has been reported to inhibit growth of multiple tumor cell 
types in vitro. The present study was assessing the cytogenetic effects of this drug on Chinese 
Hamster Ovary (CHO) cells. All experiments were performed in triplicate. The IC50 was 
22.5 ± 0.8 µg/ml. To investigate the clastogenic effects of drug, chromosomal aberration in 
metaphase cells were analyzed. Chromatid breaks and polyploidy were the main types of ab-
erration. Mitomycin-C and sodium arsenite were used as positive controls. CHO cells were 
exposed to different concentration of drug (5, 10, 15, 20 µg/ml) in 24 hours. All of the study 
aberrations and frequency of aberrant cells significantly increased as a function of digoxin 
concentration (for chromatid breaks: r = 0.881, df = 13, P < 0.001; for polyploidy: r = 0.777, 
df = 13, P = 0.001; for cells with aberrations: r = 0.926, df = 13, P < 0.001). The mitotic index 
negatively correlated with the concentration of digoxin (r = -0.978, df = 13, P < 0.001). All 
concentrations that cause chromosomal aberrations are in the cytotoxic range of the drug. The 
peak serum digoxin concentration (5 - 20 ng/ml) was very lower than concentrations we used 
in the present experiments. Further studies on valuation of chromatid breaks, micronuclei, and 
sister chromatid exchange in lymphocytes of patients who received digoxin, were recom-
mended. 
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INTRODUCTION 
Digoxin is a purified cardiac glycoside 
extracted from the foxglove plant, Digitalis 
lanata. Digoxin is widely used in the treat-
ment of various heart conditions, namely 
artial fibrillation, artial flutter and some-
times heart failure that cannot be controlled 
by other medication (Chao et al., 1992). 
Digoxin preparations are commonly mar-
keted under the trade names, such as Lan-
oxin. 
Several epidemiological studies indicat-
ed that breast cancer cells obtained from 
women on digitalis therapy (for congestive 
heart failure) were characterized by a series 
of more benign features compared with 
cancer cells from control patients (Stenkvist 
1999; Stenkvist et al., 1979, 1980, 1982; 
Goldin & Safa 1984). The growth inhibito-
ry effects of cardiac glycosides such as di-
goxin in the several cancer cell lines have 
been reported (Haux 1999; Johansson et al., 
2001; Lindholm et al., 2002; López-Lázaro 
et al., 2005; Svensson et al., 2005; Prassas 
and Diamandis 2008). Taken together, it is 
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very probable that digoxin has effect(s) on 
DNA and chromosomes.  
Considering that there is no published 
data about effect of digoxin on induction of 
chromosomal aberrations, the present study 
was carried out. The aim of the present 
study was to assess the effect of digoxin on 
chromatid and chromosomal aberrations on 
Chinese hamster ovary (CHO) cells. 
 
MATERIAL AND METHODS 
Cell culture and chromosome study 
In the present study, experiments were 
carried out using the Chinese hamster ovary 
(CHO) cell line. The cells were maintained 
in RPMI-1640 medium (from GIBCO) sup-
plemented with 10% inactivated fetal calf 
serum (from GIBCO), 2mM L-glutamine 
and with the addition of penicillin (100 
U/ml) and stereptomycin (100 mg/ml). For 
the present experiment we used Lanoxin (a 
trade name of digoxin, a liquid form, 
0.25 mg/ml; KERN Company).  
Cells were seeded into 96-well plates at 
2×104 cells/well in 100 µl complete medi-
um. After the cells clung to plates, the cells 
were treated with various concentration of 
digoxin (2.5, 5, 10, 15, 20, 25, 30, 
35 µg/ml) for 24 h. Final volume in each 
well was 200 µl. Subsequently, the cell via-
bility was measured by MTT dye reduction 
assay (Mosmann, 1983; Liu et al., 1997). 
The formazan dye was measured by ELISA 
reader. After obtaining the absorption, per-
centage inhibition of cell growth was calcu-
lated. The IC50 is defined as the cytotoxicity 
index that reduces the cell number to 50 % 
compared with untreated-control CHO 
cells.  
Mitomycin-C (0.06 µg/ml) and sodium 
arsenite (1 µgM) were used as positive con-
trols (Mahata et al., 2004; Celikler et al., 
2008; Samuel et al., 2011; Sulaiman, 2012; 
Sedigh-Ardakani et al., 2013). The CHO 
cells were seeded at the density of 1.8 ×106 
cells/petridish in the volume of 10 ml. After 
48 h, the cells were treated with different 
doses of digoxin (5, 10, 15 and 20 µg/ml) in 
RPMI-1640 for 24 h. Chromosomes were 
conventionally stained with Giemsa.  
The metaphases were analyzed for the 
numbers and types of chromosome aberra-
tions. Chromosome aberrations were classi-
fied to chromatid breaks and polyploidy. To 
determine the mitotic index (percentage of 
cells in mitosis), 1000 cells in each slide 
were observed. In each slide, 100 mitotic 
cells were counted to determine the chro-
mosome aberrations.  
All experiments (for determining either 
cytotoxiciy or chromosomal breakage) were 
performed in triplicate. 
 
Statistical analysis 
The level of the chromatid and chromo-
some breaks and also polyploidy, cells with 
aberrations and mitotic index are presented 
as mean + standard deviation (SD). Com-
parisons of the mean values of the studied 
indices were done using one way analysis 
of variance. We used Duncan test as a Post 
hoc test.  
Statistical analysis was performed using 
SPSS statistical software package (version 
11.5) for windows (SPSS Inc., Chicago, IL, 
USA). A probability of P < 0.05 was con-
sidered statistically significant. All P-values 
were two-tailed. 
 
RESULT AND DISCUSSION 
Effect of digoxin on proliferation of 
CHO cells was investigated. After 24 h 
treatment of CHO cells with 2.5, 5, 10, 15, 
20, 25, 30, 35 g/ml of digoxin, the percent 
of cell inhibition were 4.5, 9.4, 19.4, 28.3, 
39.9, 60.8, 83, and 97, respectively (Fig-
ure 1). Percent of growth inhibition rate in-
creased as a function of digoxin concentra-
tion (r = -0.980, df = 25, P < 0.001). The 
IC50 for digoxin was estimated 22.5 ± 
0.81 µg/ml.  
The results of chromosome aberration 
test were presented in Table 1. There were 
significant difference between positive con-
trols and negative control for frequencies of 
chromatid breaks and polyploidy (For all 
comparisons P-values were less than 0.01). 
Digoxin at final concentration of 25 g/ml 
results very low metaphases, therefore, the 
analysis did not perform. All of the study 
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aberrations and frequency of aberrant cells 
significantly increased as a function of di-
goxin concentration (for chromatid breaks: 
r = 0.881, df = 13, P < 0.001; for polyploi-
dy: r = 0.777, df = 13, P = 0.001; for cells 
with aberrations: r = 0.926, df = 13, 
P < 0.001). However, the mitotic index 
negatively correlated with the concentration 
of digoxin (r = -0.978, df = 13, P < 0.001). 
Based on more than a thousand pub-
lished scientific articles, it is well estab-
lished that using in vitro system, cardiac 
glycosides showed anti-cancer properties 
(Prassas and Diamandis, 2008). Although 
the molecular mechanisms under lying the 
increased susceptibility to cancer cells to 
cardiac glycosides are not fully elucidated, 
some mechanisms such as alterations in 
homeostasis of K+, Na+, and Ca2+, inhibi-
tion of tumor necroses factor and nuclear 
factor B, increased production of reactive 
oxygen species, inhibition of toposiomerase 
II, etc, might be involved (McConkey et al., 
2000; Prassas and Diamandis, 2008). Con-
sidering that digoxin increased the frequen-
cy of chromatid and chromosome breaks, it 
is suggested that digoxin may interact with  
 
Figure 1: Effect of digoxin concentration on CHO cell line for 24 hours: The results are presented as 
percent of inhibition of cell growth obtained by MTT assay. Data are mean ± SD of triplicate cultures. 
 
Table 1: Induction of chromatid breaks, polyploidy and mitotic index in CHO cells by digoxin  
Treatment 
Aberrations per 100 metaphases 
Cells with 
aberrations (%) 
Mitotic index 
(%) Chromatid 
breaks Polyploidy 
Digoxin (µg/ml) 
0   4.3 ± 1.53a   5.6 ± 3.21a 5.30 ± 0.58a 7.8 ± 0.10a 
5   4.6 ± 0.58a   5.0 ± 1.00a  7.67 ± 1.53ab 6.1 ± 0.20b 
10   6.0 ± 1.00a   5.6 ± 1.16a 11.0 ± 1.00b 5.4 ± 0.15c 
15 12.3 ± 4.16b 10.6 ± 1.53b 25.6 ± 0.58c 4.5 ± 0.25d 
20 16.0 ± 1.00b 11.6 ± 1.53b 28.0 ± 5.57c 3.6 ± 0.26e 
25 Very low metaphases   
Statistical analysis 
F (df = 4, 10) 18.59 30.06 47.63 187.28 
P-value < 0.001 0.003 < 0.001 < 0.001 
Positive controls 
MMC (0.06 µg/ml) 35.0 ± 8.02 20.6 ± 2.88 51.6 ± 3.21 3.7 ± 0.10 
Sodium arsenite (1 µM) 25.3 ± 8.02 15.0 ± 4.35 38.6 ± 1.52 3.3 ± 0.20 
Note: The results are average of three independent experiments. Same alphabets mean no statistically significant difference 
between groups (P > 0.05). 
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DNA and subsequently inhibits cell divi-
sion. The peak serum digoxin concentration 
(5-20 ng/ml) was much lower than concen-
trations we used in the present experiments 
(Marcinkowska-Królewicz and Feldmann, 
1998; Tayrouz et al., 2003; Kothare et al., 
2005). Based on the results of the present 
study, all concentrations that cause chromo-
somal aberrations are in the cytotoxic range 
of digoxin. 
Tissue specific response to DNA and 
chromosomal damages due to drugs were 
reported. Therefore, it is possible that di-
goxin shows different patterns level of tox-
icity depended to cell type. On the other 
hand patients are exposed for longer periods 
compared to our cell culture system. Taken 
together, it is necessary to evaluate the 
chromatid breaks, micronuclei, and sister 
chromatid exchange in lymphocytes of pa-
tients who received digoxin.  
Finally it should be mentioned that di-
goxin must be used cautiously in generally 
and particularly in children and pregnant 
women. Further experiments are necessary 
to clarify the significance of the present 
findings. 
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